INSIGHTS ON CLINICAL TRIAL PARTNERING
-
Harness An Adept IRB's Expertise To Streamline Study Design
An Institutional Review Board protects human research participants by evaluating study ethics, consent, and risks, while providing sponsors with ongoing guidance on complex trial protocols.
-
Clinical Trial Budgeting Faces Pressure To Modernize
Outdated budget data slows trial startup. Real-time market benchmarking helps sites and sponsors negotiate faster and get treatments to patients sooner.
-
Turning Innovation Into Execution In CNS Trials
SCOPE 2026 experts called for practical planning, iterative testing, and real‑world workflows in mental health research, highlighting mock visits, expanded roles, engagement, and psychedelic safety.
-
Scaling Outsourced Clinical Trial Services
Scaling outsourced clinical services increases operational pressure. Here’s where strain appears, how structure absorbs volume, and what sponsors should evaluate as programs expand.
-
Community-Focused Site Networks Increase Access And Trial Reach9/23/2025
Community-based site networks enhance clinical trial equity by engaging diverse populations, improving enrollment, retention, and developing therapies effective across varied patient groups.
-
A Day In The Life Of A Clinical Research Site4/22/2025
Clinical research site coordinators are the unsung heroes of trial execution—managing complex protocols, supporting participants, and navigating fragmented systems, all while ensuring study integrity.
-
One Program. Many Studies: How Experts Keep It All Aligned.2/6/2026
Compare the differences between project and program management in drug development, and how an integrated CRO ensures oversight and continuity from early development through clinical execution.
-
Routes To Sponsor Of Choice: Shared Pipelines, Streamlined Payments10/30/2024
Paying clinical trial sites consistently on time provides stability and maintains positive relationships. Learn why being a sponsor of choice can mean the adoption of a singular clinical trial payments solution.
-
Reducing Supply Risk in Cell & Gene Therapy Trials7/31/2026
In cell and gene therapy trials, success depends on coordination. Learn how visibility, workflow control, and alignment help reduce risk and protect patient-specific treatments.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
Looking for faster trial startup, diverse participant pools, and consistent site quality? Explore a vaccine research network designed to keep your study on time and on target.
-
Flexibility matters. Scout helps you plan hybrid and virtual meetings that connect global teams and keep every attendee engaged.
Whether in-person, online, or both, our hybrid meeting solutions for clinical trials make collaboration simple, secure, and human.
-
Review PCI's commitment to environmental and social responsibility, including its ambitious sustainability goals and achievements across various categories.
-
Plan face-to-face, virtual, and hybrid life sciences events with precision using an end-to-end service that plans everything from investigator meetings to advisory boards and incentive trips.
-
Overcome the complexities of CNS clinical trials with patient-centric study designs, global site networks, and expert oversight to ensure faster recruitment and efficient regulatory submissions.